BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.30 (-1.07%)
At close: Jan 21, 2026
BRIM Biotechnology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 3.17 | 0.33 | 0.09 | 0.53 | 0.36 | 90.77 | Upgrade | |
Revenue Growth (YoY) | 1933.33% | 270.00% | -82.89% | 46.11% | -99.60% | - | Upgrade |
Cost of Revenue | 1.82 | 0.31 | - | - | - | - | Upgrade |
Gross Profit | 1.35 | 0.02 | 0.09 | 0.53 | 0.36 | 90.77 | Upgrade |
Selling, General & Admin | 126.17 | 106.31 | 112.33 | 72.96 | 44.97 | 40.36 | Upgrade |
Research & Development | 266.56 | 238.5 | 581.88 | 145.89 | 48.6 | 205.81 | Upgrade |
Operating Expenses | 392.73 | 344.81 | 694.22 | 218.85 | 93.58 | 246.17 | Upgrade |
Operating Income | -391.38 | -344.79 | -694.13 | -218.33 | -93.22 | -155.4 | Upgrade |
Interest Expense | -0.36 | -0.09 | -0.15 | -0.08 | -0.11 | -0.07 | Upgrade |
Interest & Investment Income | 33.3 | 32.9 | 21.8 | 0.83 | 0.5 | 1.34 | Upgrade |
Earnings From Equity Investments | -19.46 | -27.03 | -24.59 | -62.62 | -47.94 | -9.66 | Upgrade |
Currency Exchange Gain (Loss) | -13.68 | 23.53 | 9.03 | 5.9 | -1.76 | -10.25 | Upgrade |
Other Non Operating Income (Expenses) | 0.01 | - | 0 | 0.02 | 4.21 | 1.47 | Upgrade |
EBT Excluding Unusual Items | -391.57 | -315.47 | -688.04 | -274.28 | -138.32 | -172.57 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 26.77 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.01 | - | 32.87 | 48.79 | Upgrade |
Pretax Income | -391.57 | -315.47 | -688.02 | -274.28 | -105.45 | -97.01 | Upgrade |
Income Tax Expense | - | - | - | - | - | 9.14 | Upgrade |
Earnings From Continuing Operations | -391.57 | -315.47 | -688.02 | -274.28 | -105.45 | -106.15 | Upgrade |
Minority Interest in Earnings | 3.87 | - | - | - | - | 18.21 | Upgrade |
Net Income | -387.7 | -315.47 | -688.02 | -274.28 | -105.45 | -87.94 | Upgrade |
Net Income to Common | -387.7 | -315.47 | -688.02 | -274.28 | -105.45 | -87.94 | Upgrade |
Shares Outstanding (Basic) | 129 | 117 | 101 | 71 | 59 | 59 | Upgrade |
Shares Outstanding (Diluted) | 129 | 117 | 101 | 71 | 59 | 59 | Upgrade |
Shares Change (YoY) | 11.49% | 16.02% | 41.02% | 20.23% | 0.72% | 0.16% | Upgrade |
EPS (Basic) | -3.00 | -2.70 | -6.84 | -3.85 | -1.78 | -1.49 | Upgrade |
EPS (Diluted) | -3.00 | -2.70 | -6.84 | -3.85 | -1.78 | -1.49 | Upgrade |
Free Cash Flow | -616.52 | -282.14 | -599.15 | -172.98 | -113.35 | -127.48 | Upgrade |
Free Cash Flow Per Share | -4.78 | -2.42 | -5.96 | -2.43 | -1.91 | -2.17 | Upgrade |
Gross Margin | 42.59% | 6.61% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | -12338.49% | -103539.04% | -771250.00% | -41506.84% | -25893.06% | -171.21% | Upgrade |
Profit Margin | -12222.57% | -94735.74% | -764468.89% | -52143.92% | -29291.39% | -96.89% | Upgrade |
Free Cash Flow Margin | -19436.26% | -84726.73% | -665723.33% | -32885.74% | -31485.83% | -140.45% | Upgrade |
EBITDA | -362.22 | -339.66 | -692.92 | -218.02 | -93.01 | -155.08 | Upgrade |
EBITDA Margin | - | - | - | - | - | -170.86% | Upgrade |
D&A For EBITDA | 29.16 | 5.12 | 1.2 | 0.31 | 0.2 | 0.32 | Upgrade |
EBIT | -391.38 | -344.79 | -694.13 | -218.33 | -93.22 | -155.4 | Upgrade |
EBIT Margin | - | - | - | - | - | -171.21% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.